Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study

被引：0
|
作者：
Tatsuo Hosoya
Takafumi Sano
Tomomitsu Sasaki
Masahiko Fushimi
Tetsuo Ohashi
机构：
[1] Jikei University School of Medicine,Medical R&D Division, Development Department
[2] Fuji Yakuhin Co.,undefined
[3] Ltd.,undefined
来源：
Clinical and Experimental Nephrology | 2020年 / 24卷
关键词：
Hyperuricemia; Gout; Selective urate reabsorption inhibitor; URAT1 inhibitor; Dotinurad; FYU-981;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：44 / 52
页数：8
相关论文
共 50 条
  • [1] Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study
    Hosoya, Tatsuo
    Sano, Takafumi
    Sasaki, Tomomitsu
    Fushimi, Masahiko
    Ohashi, Tetsuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (SUPPL 1) : 44 - 52
  • [2] Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study
    Hosoya, Tatsuo
    Sano, Takafumi
    Sasaki, Tomomitsu
    Fushimi, Masahiko
    Ohashi, Tetsuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (SUPPL 1) : 53 - 61
  • [3] Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study
    Tatsuo Hosoya
    Takafumi Sano
    Tomomitsu Sasaki
    Masahiko Fushimi
    Tetsuo Ohashi
    Clinical and Experimental Nephrology, 2020, 24 : 53 - 61
  • [4] Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
    Hosoya, Tatsuo
    Sano, Takafumi
    Sasaki, Tomomitsu
    Fushimi, Masahiko
    Ohashi, Tetsuo
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2020, 24 (SUPPL 1) : 62 - 70
  • [5] Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
    Tatsuo Hosoya
    Takafumi Sano
    Tomomitsu Sasaki
    Masahiko Fushimi
    Tetsuo Ohashi
    Clinical and Experimental Nephrology, 2020, 24 : 62 - 70
  • [6] Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double-blind, placebo-controlled study
    Hosoya, T.
    Sasaki, T.
    Hashimoto, H.
    Sakamoto, R.
    Ohashi, T.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) : 298 - 305
  • [7] Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study
    Okubo, Kimihiro
    Gotoh, Minoru
    Asako, Mikiya
    Nomura, Yasuyuki
    Togawa, Michinori
    Saito, Akihiro
    Honda, Takayuki
    Ohashi, Yoshihiro
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (01) : 97 - 105
  • [8] Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study
    Inoue, Yuichi
    Shimizu, Tetsuo
    Hirata, Koichi
    Uchimura, Naohisa
    Ishigooka, Jun
    Oka, Yasunori
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    SLEEP MEDICINE, 2013, 14 (11) : 1085 - 1091
  • [9] Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study
    Li, Yanpeng
    Zhang, Ruoxi
    Zhou, Yanling
    Bao, Cungang
    Lin, Zhaocun
    Chen, Chunyan
    He, Jingjing
    Jin, Zhiping
    Song, Lihua
    Zhang, Min
    Guo, Sigen
    Jiang, Yu
    Zhao, Zhongxin
    SLEEP, 2024, 47 (02)
  • [10] Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study
    Hide, Michihiro
    Yagami, Akiko
    Togawa, Michinori
    Saito, Akihiro
    Furue, Masutaka
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (02) : 317 - 325
12345